IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q4 2023 Holdings

Filed 2024-02-14 | 11 holdings | $296.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corp(LQDA)COM NEW53635D202$124.6M10,360,94542.0%
Alimera Sciences IncCOM NEW016259202$72.7M16,835,15424.5%
Anika Therapeutics Inc(ANIK)COM035255108$24.5M1,081,3608.3%
Exelixis Inc(EXEL)COM30161Q104$21.8M910,7307.4%
Standard Biotools Inc(LAB)COM34385P108$15.6M7,042,4135.2%
Evolus Inc(EOLS)COM30052C107$13.9M1,317,8564.7%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$9.8M441,8333.3%
Y-Mabs Therapeutics Inc(YMABUSD)COM984241109$7.2M1,048,4252.4%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$3.6M183,0641.2%
Adma Biologics Inc(ADMA)COM000899104$2.1M473,0870.7%
Societal Cdmo IncCOM75629F109$592.3K1,689,7680.2%